Queensland makes pharmacy prescribing permanent The RACGP has called out the decision to make the pilot programs a permanent fixture, raising concerns about patient safety and the precedent it sets.
New guidance on driving and medicinal cannabis The GP-led, practical resources aim to support doctors considering medicinal cannabis treatment for patients who choose to drive.
TGA strengthens warnings on antibiotic side effects GPs have been asked to use fluoroquinolones ‘judiciously’, as the Administration rolls out more prominent warnings.
New step-by-step care transition guide for GPs A first-of-its-kind, practical resource is now available to GPs, designed to help navigate the often high-risk task of moving patients between care providers.
Study reveals mental health toll of workplace injury It found an injury done at work may be worse for mental health than an injury sustained elsewhere, with GPs to take a ‘holistic approach’.
Wegovy approved for cutting cardiovascular disease risk The TGA has approved semaglutide (sold as Wegovy) as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in overweight and obese adults.
ADHD med shortages ‘a merry-go-round you just can’t predict’ The new school year has coincided with another series of shortages, forcing patients and prescribers to rethink their options.
‘A big difference’: Poisons Standard change brings hope Reduced paracetamol pack sizes are now in force, as a new report highlights the number of children hospitalised due to preventable medicine-related issues.
Most GPs discover medication shortages through patients: Poll A new survey highlights the urgency of improving measures to communicate supply chain disruptions, with patients increasingly feeling an impact.
TGA updates montelukast safety information Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.